Prevalence of Abuse Among Patients With Rheumatic Diseases
- Conditions
- Abuse NeglectAbuseRheumatic Diseases
- Interventions
- Other: Rheumatic diseases Mistreatment Scale (RDMS)Other: Health Assessment Questionnaire (HAQ)Other: Depression, Anxiety and Stress Scale (DASS-21)Other: Brief Resilient Coping ScaleOther: WHOQOL-BREFOther: Routine assessment of patient index data 3 (RAPID-3)Other: Big Five InventoryOther: Family APGAR Questionnaire
- Registration Number
- NCT06233760
- Lead Sponsor
- National Institute of Medical Sciences and Nutrition, Salvador Zubiran
- Brief Summary
Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.
Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.
The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.
- Detailed Description
Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes.
In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights violation.
In 2012 Giraldo-Rodríguez developed and validated the Geriatric Abuse Scale (GAS), an instrument that, with adequate psychometric properties, reported a prevalence of abuse of 10.28% in Mexico.
Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability.
The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 244
- Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate
- Patients with a not confirmed rheumatic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with rheumatic diseases Health Assessment Questionnaire (HAQ) All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases WHOQOL-BREF All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Family APGAR Questionnaire All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Depression, Anxiety and Stress Scale (DASS-21) All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Big Five Inventory All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Brief Resilient Coping Scale All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Routine assessment of patient index data 3 (RAPID-3) All the rheumatic diseases outpatients from the National Institute of Medical Sciences Patients with rheumatic diseases Rheumatic diseases Mistreatment Scale (RDMS) All the rheumatic diseases outpatients from the National Institute of Medical Sciences
- Primary Outcome Measures
Name Time Method Number of Mexican patients with RD who will present the phenomenon of mistreatment At inclusion (baseline moment) (cross-sectional study) Identify the percentage of patients with rheumatic diseases that present mistreatment using the instrument developed by Giraldo-Rodríguez et al (translation, cultural adaptation, and validation performed)
- Secondary Outcome Measures
Name Time Method Identify factors associated with mistreatment among patients with rheumatic diseases At inclusion (baseline moment) (cross-sectional study) Identify factors associated with mistreatment among patients with rheumatic diseases using an instrument locally development
Trial Locations
- Locations (1)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
🇲🇽Mexico City, Mexico